Skip to main content
Antibiotics logoLink to Antibiotics
. 2020 Apr 29;9(5):219. doi: 10.3390/antibiotics9050219

Antibiotics: A Bibliometric Analysis of Top 100 Classics

Anas Imran Arshad 1,2, Paras Ahmad 3, Mohmed Isaqali Karobari 4, Jawaad Ahmed Asif 5, Mohammad Khursheed Alam 6, Zuliani Mahmood 1,*, Normastura Abd Rahman 7, Noraida Mamat 1, Mohammad Amjad Kamal 8,9,10
PMCID: PMC7277750  PMID: 32365471

Abstract

Citation frequencies represent the most significant contributions in any respective field. This bibliometric analysis aimed to identify and analyze the 100 most-cited publications in the field of antibiotics and to highlight the trends of research in this field. “All databases” of Clarivate Analytics’ Web of Science was used to identify and analyze the 100 publications. The articles were then cross-matched with Scopus and Google Scholar. The frequency of citation ranged from 940 to 11,051 for the Web of Science, 1053 to 10,740 for Scopus, and 1162 to 20,041 for Google Scholar. A total of 513 authors made contributions to the ranked list, and Robert E.W. Hancock contributed in six articles, which made it to the ranked list. Sixty-six scientific contributions originated from the United States of America. Five publications were linked to the University of Manitoba, Canada, that was identified as the educational organization, made the most contributions (n = 5). According to the methodological design, 26 of the most cited works were review-type closely followed by 23 expert opinions/perspectives. Eight articles were published in Nature journal, making it the journal with the most scientific contribution in this field. Correlation analysis between the publication age and citation frequency was found statistically significant (p = 0.012).

Keywords: citation classics, top-cited articles, antibiotics, bibliometric analysis, antibacterial, antimicrobials

1. Introduction

The bibliometric analysis provides a quantitative review of literature in any field of research based on the citation frequency of the conducted research. This type of analysis identifies the countries, organizations, and authors who were affiliated with the most prominent scientific contributions [1,2]. The thrust areas of the past research in a specialty can be identified by analyzing the most-cited work currently, which information can then be used to channel the future research.

The bibliometric concept of “citation classics” was described by the founder of the Institute for Scientific Information (ISI), Dr Eugene Garfield, in 1977. Its purpose was identification as well as acknowledgment of frequently cited research of authors and their peers that would consequently encourage the respective work and its impact on the specialty [3]. The eligibility of a scientific contribution to be counted as a “classic” depends on the specialty being analyzed. While some analysts believe that 100 or more citations of a publication are sufficient [4,5,6,7], others believe that a publication must be cited more than 400 times to be counted in the list [8]. Leading scientific databases like Web of Science (WoS), Elsevier’s Scopus (ES), and Google Scholar (GS) and influential publishers like BioMed Central, Nature, Wiley, Frontiers, Elsevier, and PLOS are developing and embedding options to perform on-site citation analysis [4,8,9,10,11].

Several bibliometric analyses have been conducted in other fields of health sciences, which include the specialty of dentistry [4,8,9,12,13] and medicine [14,15,16,17,18]. However, the “classics” in the field of antibiotics has not been identified. The aim is to identify and analyze the top 100 classics in the specialty of antibiotics to highlight the notable advancements made on this very topic over the recent decades.

2. Materials and Methods

2.1. Search Strategy

Two independent reviewers (A.I.A) and (P.A) conducted a literature search on 21st March 2020 using ‘All-Databases’ collection of WoS. The search terms were identified after consulting field experts from different institutions, and a final search string was developed and agreed upon unanimously. No language restrictions, publication year range, or methodology selections were applied.

2.2. Eligibility Criteria

Titles of the articles published in peer-reviewed journals were selected when either of the following search terms identified: “antibiotics” OR “antibiotic” OR “anti-bacterial” OR “antibacterial” OR “anti-infective” OR “anti-infectious” OR “anti-microbial” OR “antimicrobial”.

Articles having less than 400 citations according to the WoS and ES databases were excluded. Articles published in low or no impact factor journals were not included in the marked list.

2.3. Data Extraction and Bibliometric Parameters

A total of 124,122 publications were initially identified using the search string described above. The publications were sorted based on the frequency of citations in a descending manner. The list of top 100 classics was marked based on the citation frequency. The marked list was then cross-matched with GS and ES databases. The marked lists from the A.I.A and P.A was then shared with the field experts, and all authors unanimously agreed upon the final list. Bibliometric parameters for the articles available in “All Databases” were recorded from the WoS database, which includes the title of the article, journal title, citation count, current citation index (CCI) 2019 (total citations received in 2019), publication year, names of authors along with their affiliated organizations, and country of origin. Each publication was then hand-searched to identify evidence level, keywords, and the methodology of the study. The missing data was then cross-matched with the ES database to ensure the accuracy and correctness of collected information.

2.4. Methodological Design

The publications were then categorized according to the methodology of the study as review articles, expert opinion, clinical practice guidelines, cross-sectional study, new material or technique, clinical studies, and laboratory studies.

2.5. Institution and Country of Origin

The author’s affiliation and origin country of publication were retrieved from the ES database as complete information for the marked list was not available from the WoS database. The retrieved information was then hand-searched and compared with the original text for each manuscript. Although corresponding addresses are considered a reliable source to identify the country of origin of publication; however, upon searching manually, it was seldom recorded. Each institution contributing to the publication was recorded as a single entry.

2.6. Data Analysis

The “Visualization of Similarities (VOS) viewer software” is widely used to graphically illustrate the bibliometric parameters in mapping networks, which allow easy visualization of critical elements [2,19,20,21]. The current study used VOS to represent a graphical mapping of keywords as identified bibliometric analysis to identify the focus of research in recent decades.

2.7. Statistical Analysis

The descriptive data and associations of citation frequency, citation density, publication age, and CCI were analyzed using IBM SPSS Statistics®, version 22, using the Spearman rank test. The normality of data was checked using the Shapiro–Wilk test. To explore the difference between two or more independent groups, the Kruskal–Wallis test was performed. Post-hoc testing was performed to confirm the difference between variables. Mann–Kendall trend test was performed to determine increasing and decreasing time trends. A p-value of < 0.05 was considered statistically significant.

3. Results

3.1. Bibliometric Parameters

The marked list of top 100 classics received a sum of 167,320 citations based on WoS, 165,947 citations based on ES, and 262,727 based on the GS database. The frequency of citations ranged from 940 to 11,051 (WoS), 1053 to 10,740 (ES), and 1162 to 20,041 (GS). Citation density is defined as the average number of citations/annum; it was calculated as 2742 (WoS), 2720 (ES), and 4307 (GS) for the 100 classics. “Antibiotic susceptibility testing by a standardized single disk method” was identified as the most cited “classic” with 11,051, 10,740, and 20,041 citations according to WoS, ES, and GS databases, respectively, with a citation density of 205 [22]. “Antimicrobial peptides of multicellular organisms” was ranked second with 5685, 5668, 7994 citations according to WoS, ES, and GS databases, respectively, with a citation density of 316 [23]. “Transformation of mammalian cells to antibiotic resistance with a bacterial gene under the control of the SV40 early region promoter” was ranked third with 3891, 2319, 3875 citations according to WoS, ES, and GS databases, respectively, with a citation density of 102 [24]. The marked list of top 100 classics along with their citation frequency from WoS, ES, and GS databases, publication age, citation density, and CCI 2019 is presented in Table 1. Shapiro–Wilk test revealed non-normal data on the citation frequency, citation density, and age of publication (years). Figure 1a shows a statistically significant upward trend of citation frequency was noted with the increase in publication age (R2 = 0.044, p = −0.012). Figure 1b shows a downward trend of citation density was noted with an increase in the age of publication (R2 = 0.304, p = −0.551), which was not statistically significant. The Supplementary Figure S1 illustrates the distribution of citation frequency over the last six decades.

Table 1.

List of 100 classics of antibiotics ranked based on their citation frequency according to the Web of Science, Scopus, and Scholar databases along with citation density and current citation index (2019).

R 1 Author [Reference] Year CD 2 CCI 3 2019 WoS 4 ES 5 GS 6
1 Bauer, Kirby, Sherris, and Turck [22] 1966 205 621 11,051 10,740 20,041
2 Zasloff [23] 2002 316 398 5685 5668 7994
3 Southern and Berg [24] 1982 102 3 3891 2319 3875
4 Cowan [25] 1999 179 292 3749 4598 11203
5 Sondi and Salopek-Sondi [26] 2004 212 353 3397 3677 5471
6 Brogden [27] 2005 224 302 3363 3353 4941
7 Kumar et al. [28] 2006 214 291 2996 3185 5039
8 Cohen et al. [29] 1972 59 17 2809 1775 3754
9 Kim et al. [30] 2007 201 311 2615 2818 4164
10 Stewart and Costerton [31] 2001 130 217 2474 2602 4113
11 Hancock and Sahl [32] 2006 170 139 2373 2391 3185
12 Kovach et al. [33] 2006 167 244 2337 2319 3019
13 Liu et al. [34] 1995 93 166 2332 2458 3571
14 Dorman and Deans [35] 2000 110 177 2201 2407 4479
15 Sharma et al. [36] 2009 188 240 2071 2269 3196
16 Mah and O’Toole [37] 2001 108 183 2043 2127 3529
17 Neu [38] 2003 116 119 1970 2071 3413
18 Chopra and Roberts [39] 2001 104 230 1967 2026 3414
19 Davies and Davies [40] 2009 178 312 1963 2037 3817
20 Ganz [41] 2010 195 395 1952 1983 3115
21 Zasloff [42] 2006 138 257 1935 1805 2643
22 Kuemmerer [43] 1992 69 82 1930 2007 2734
23 Dellit et al. [44] 1987 58 67 1915 1951 1732
24 Wiegand et al. [45] 2010 187 146 1871 1898 2848
25 Yeaman and Yount [46] 2007 144 146 1869 1846 2702
26 Nathan et al. [47] 2003 108 169 1842 1246 2033
27 Cushnie and Lamb [48] 2008 153 384 1839 2052 3983
28 Goossens et al. [49] 2005 121 230 1811 1850 2904
29 Sarmah et al. [50] 1983 47 31 1737 1817 2638
30 Kumarasamy et al. [51] 2005 115 149 1726 1842 3071
31 Mast et al. [52] 2005 115 70 1719 645 1868
32 Rabea et al. [53] 2003 99 171 1689 1719 2523
33 Anthonisen et al. [54] 2001 87 38 1650 1898 3065
34 Magill et al. [55] 1987 49 57 1633 1601 2294
35 Niederman et al. [56] 2014 260 337 1562 1893 2319
36 Liang et al. [57] 1999 74 96 1552 1525 2168
37 Zankari et al. [58] 2001 80 81 1518 1489 2039
38 Gewirtz [59] 2006 108 102 1512 1550 2177
39 Steers et al. [60] 2006 106 121 1482 596 1288
40 Hirsch et al. [61] 1999 70 82 1474 1549 2469
41 Jenssen et al. [62] 2012 184 484 1468 1462 2257
42 Laxminarayan et al. [63] 1959 24 1 1453 1454 2387
43 Park et al. [64] 1995 58 30 1447 1511 2483
44 Kohanski et al. [65] 2002 79 22 1421 1431 2062
45 Shai [66] 2013 201 326 1410 1403 1990
46 Boman [67] 2007 108 147 1405 1420 2100
47 Hoiby et al. [68] 1999 66 65 1391 1395 2249
48 Dethlefsen et al. [69] 2010 137 201 1372 1373 1981
49 Hughes et al. [70] 2008 112 124 1347 1641 1790
50 Nathan and Hibbs [71] 1999 64 99 1346 1230 1789
51 Li et al. [72] 1991 46 25 1336 1399 1975
52 Hidron et al. [73] 2008 111 72 1334 1418 2028
53 Hammer et al. [74] 2008 110 146 1323 1492 3055
54 Ong et al. [75] 2002 71 70 1286 1446 2058
55 Herrero et al. [76] 2011 142 165 1280 1205 1714
56 Burke [77] 1999 61 45 1278 1007 1773
57 Kollef et al. [78] 2001 67 45 1269 1462 2254
58 Freifeld et al. [79] 2000 63 45 1259 1493 2753
59 Ibrahim et al. [80] 1990 41 46 1243 1405 2098
60 Pigeon et al. [81] 1961 21 18 1234 1268 1917
61 Bennett et al. [82] 2009 112 149 1232 704 1187
62 Chambers and DeLeo [83] 1994 47 29 1213 1209 2058
63 Davies [84] 1966 22 4 1194 1294 2295
64 Cherepanov and Wackernagel [85] 2010 117 184 1171 1157 1708
65 Kong et al. [86] 1995 46 79 1154 1233 1741
66 Hamblin and Hasan [87] 2000 58 33 1153 1226 1740
67 Carter et al. [88] 1985 33 34 1152 1155 1677
68 Ganz et al. [89] 2004 72 112 1152 1024 1628
69 Ceri et al. [90] 1997 49 17 1135 1159 1716
70 Classen et al. [91] 2005 75 46 1129 1318 2194
71 Ventola [92] 1992 40 34 1128 1214 2398
72 Baddour et al. [93] 1999 53 98 1119 1198 1889
73 Bartlett et al. [94] 1981 28 45 1110 949 1625
74 Lande et al. [95] 1998 50 35 1099 1119 1597
75 Harder et al. [96] 2007 84 84 1096 1128 1716
76 Hancock and Lehrer [97] 2015 218 458 1091 1055 1628
77 Shai [98] 1978 26 21 1080 1074 1500
78 Rothstein et al. [99] 2015 215 413 1075 1087 1402
79 Steiner et al. [100] 2001 56 38 1072 968 1615
80 Ruparelia et al. [101] 2005 71 58 1071 1080 1518
81 Dethlefsen and Relman [102] 1975 23 65 1045 1045 1533
82 Fischbach and Walsh [103] 1999 50 51 1044 1031 1603
83 Vezina et al. [104] 2002 58 70 1041 1118 1699
84 Hancock and Chapple [105] 2009 94 99 1034 1058 1608
85 Andersson and Hughes [106] 2011 115 161 1032 1021 1625
86 Harder et al. [107] 2006 74 144 1029 1069 1684
87 Epand and Vogel [108] 2008 85 135 1022 1009 1442
88 Ling et al. [109] 2010 101 154 1009 1010 1594
89 Cohen [110] 1999 48 35 1004 1067 1857
90 Umezawa et al. [111] 1992 35 23 990 814 1214
91 Cabello [112] 2015 198 198 989 1049 1691
92 Kenawy et al. [113] 2008 81 135 975 1000 1303
93 Hancock [114] 1997 42 30 968 991 1448
94 Moazed and Noller [115] 2008 80 84 963 900 1281
95 Baquero et al. [116] 2007 74 91 961 1015 1587
96 Spellberg et al. [117] 1966 18 17 959 988 1598
97 Wang et al. [118] 2000 48 46 956 985 1476
98 Zhang et al. [119] 1987 29 27 947 1053 1162
99 Krause et al. [120] 1993 35 30 944 950 1549
100 Prezant et al. [121] 2004 59 59 940 906 1397

1 R = rank; 2 C.D. = citation density;3 CCI = current citation index;4 WoS = Web of Science;5 ES = Elsevier Scopus;6 GS = Google Scholar.

Figure 1.

Figure 1

(a) Association of citation frequency with the age of publication (years). (b) Changes in trends of citation density with the age of publication.

3.2. Year of Publication

Chronologically, the oldest classic with 60 years of publication age was published in 1959 [60], and three articles with four years of publication age were published in 2015 [92,109,119] made it to the “classics” list. Fifty articles were published during 2000–2009, followed by 22 published during 1990–1999, 13 published during 2010–2019, seven published during 1980–1989, five published during 1959–1969, and three published during 1970–1979. Nine articles were published in 1999, marking it the year of most publications. Interestingly, 63% of the articles were published within the last two decades. The highest number of “classics” were published between 2000 and 2009 (n = 50).

3.3. Methodological Design and Evidence Level (EL)

The distribution of the list based on methodological design is illustrated in Figure 2. Based on the level of evidence, 71 publications were graded as level-V, two were graded as level-IV, one belonged to level-III, four publications were graded as level-II, and 17 were graded as level-I. The evidence level and methodological design of five publications [24,52,60,77,111] were not identified as full-text of the articles were not accessible through different electronic sources.

Figure 2.

Figure 2

Pie chart diagram showing the distribution of classic articles based on the methodology of the study.

3.4. Contributing Authors, Institutions, and Countries

Robert E.W. Hancock was identified as the most contributing, authoring six classics, followed by Tomas Ganz, who contributed in four classics. A total of 513 authors contributed to the top 100 classics, among them 26 authors were contributed in two “classics” each. Complete texts for 95 publications were obtained, and five publications were not accessible through different institutions [24,52,60,77,111]. Based on the institutional address of the corresponding author as retrieved from the ES database, individuals from 26 countries contributed to the “classic” articles. Among these, 69 scientific contributions were from the United States of America. Followed by 18 publications from Canada, 11 from Germany, and four from Sweden. Three publications originated from Belgium, China, and Israel. Two publications originated from Egypt, Denmark, and India. One publication originated from, Argentina, Croatia, Ecuador, France, Kenya, Korea, Netherlands, New Zealand, Pakistan, South Africa, South Korea, Spain, Tanzania, Thailand, United Kingdom, and Australia.

Among 246 international institutions, the greatest contribution to the “classic” articles was made by the University of Manitoba, Canada, in six classics followed by the Stanford University School of Medicine, USA, in five classics. “University of Washington, USA”, “University of British Colombia, Canada”, “The University of California at Los Angeles, USA”, and “Harvard University, USA” contributed in four classics. “University of Kiel, Germany” and “University of California at San Diego, USA” contributed in three classics. “Robert Wood Johnson Medical School, USA”, “Weizmann Institute of Science, Israel”, “Emory University, Atlanta, Georgia, USA”, “Laurentian University, Ontario, Canada”, “Rush-Presbyterian-St. Luke’s Medical Center, USA”, “St. Agnes Medical Center, USA”, “the Centers for Disease Control and Prevention, Atlanta, Georgia, USA”, and “Veterans Affairs Palo Alto Health Care System, California, USA” contributed to two classics each.

3.5. Journal of Publication

The 100 classics were published across 63 different journals. Figure 3 presents the list of journals in which the highest number of classics were published. The list of the remaining journals is available as Supplementary Table S1.

Figure 3.

Figure 3

Bar graph representation of the number of articles published in different journals

3.6. Keywords

The most frequently occurring keywords in the top 100 classics were “anti-bacterial agents” and “antibiotic agent”, followed by “antibiotic resistance”, “anti-infective agent”, and “antimicrobial”. Figure 4 is a graphical presentation of keywords arranged in a network of clusters. Colorful nodes represent the linkage of specific keywords to each cluster. Table S2 enlists the total number of index keywords and their frequency of occurrence based on the Elsevier Scopus database.

Figure 4.

Figure 4

Network analysis of keywords identified from top 100 classics of antibiotics

4. Discussion

The current study identified and analyzed the top 100 classics on antibiotics, antimicrobials, or antibacterial agents. Identification of any scientific contribution and inclusion in classics warrants the excellence and acclaimed acknowledgment by the relevant field experts, researchers, and scientists [12]. Theoretically, a higher citation frequency of a publication indicates the quality of the research conducted as identified by the scientific community [122]. Identification is imperative to study whether the classics have elaborated or explored the understanding of a problem and/or provided a comprehensive approach towards its solution, or whether the publication introduced a research trend or provided an expert opinion/summary on a topic of interest. The results of this study present the research perspective in the field of antibiotics, antimicrobials, or antibacterial agents for the last six decades. Additionlly, it illustrates key trends of research as well as clinical practice [2,8].

The definition of “classics” largely depends on the research field/specialty to which the publication belongs. In some fields, 100 or more citations of a publication are considered enough to classify it as a “classic” [6]. In perspective, the article ranked as 100th in the current study received 940 citations in comparison with the article ranked as 1st in the field of physics research in Korea that received 302 citations [123] or with the article ranked as 1st in the dental caries research that received 2003 citations [19]. For the current study, the publications receiving more than 400 citations can be considered classics. However, these publications will not make it to the top 100 due to the immense availability of the highly cited publications.

Web of Science was used as a benchmark database because it has citation metrics from 1945 to the present [124]. A significant variance was observed when the citation metrics were cross-matched with other databases. The Elsevier Scopus database reports the citations dated back to 1996, which is a severe flaw while figuring out the most-cited papers. In contrast, the Google Scholar database counts the citations based on published articles, books, conference proceedings, thesis/dissertations, technical reports, and preprints, which explains the higher citation counts reported in the current study [2].

The current study found a statistically significant correlation of the citation frequency with the age of publication, which is similar to the findings of a previous bibliometric analysis report [2]. Although there was an upward trend of citations received by the classics to the age of publication [125], the trend analysis of the influence of age of publication on the citation density revealed that certain topics after reaching maturity show a decrease in citation density. This change in trend can be also be noticed from the current citation index 2019.

It has been reported that the actual impact of a publication can only be assessed at least two decades after it has been published [2,4,17]. Interestingly, this phenomenon has been observed in the current study as the most number of classics were published in 1999. However, it is noteworthy that with the changing trends of how published work is reviewed, the accessibility of literature has increased multifold, and research from around the world can be remotely reviewed without needing access to archives, libraries, and published paper journals. This debate is backed up by the current study, which observed that 63 classics were published during the last two decades. This finding indicates that in the current era of digital technology, classics might require lesser years to reach their maturity stage.

With the evolution of research, several guidelines have been introduced to fulfill the ever-growing need for organized reporting of observational studies [126], laboratory studies [127], clinical studies [128], or reviews [129]. These guidelines allow the scrutinization of scientific information and improve the quality and transparency of reports. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement is used to report systematic review and meta-analysis mainly focusing on evaluating randomized trials to provide the highest level of evidence. Surprisingly, the current study did not identify any systematic review of literature or meta-analysis, which made it to the list. The title of the study report is another key element which is stressed upon in various guidelines. It is entirely possible that some classics were not identified in the current study owing to how their titles were designed. A title should explicitly describe the methodology of study and key elements which identify the study to allow proper indexing of the article.

Keywords play an essential role in the discoverability of any published article [130]. While searching any specific type of literature, scholars tend to methodically utilize search terms which are generally used in a specific field [131]. In this study, prime examples of such terms are antibiotics, antibacterials, or antimicrobials. However, it was noted that keywords only appeared in articles published after 1995 and more so not mandatorily in every publication. It was noted that even though keywords might have been submitted in the journal database during submission of manuscripts, the published articles did not display the keywords [55,63,109]. These incoherencies make the network analysis of keywords somewhat misleading and inconsistent with the actual data if we only rely on hand-searching. Therefore, the ES database was utilized to retrieve the relevant data to allow a presentable and fair network analysis.

5. Limitations

Firstly, a large amount of “classic” articles had to be excluded from the list as it was not considered possible to perform the bibliometric analysis of 500 or more articles in the current study. Therefore, the top 100 classics which achieved the maximum citations were selected for the present study. Secondly, the most recently published research papers are at a disadvantage irrespective of their content and quality, since they were outside the time window considered. Under this spectrum, it would not be wrong to say that the real impact of a research article cannot be accurately determined for at least five years post-publication.

6. Conclusions

This bibliometric analysis of the top 100 classics on antibiotics revealed that the increase in the age of publication positively influenced the citation frequency. Unlike times before 1996, the explosion of access to scientific articles in the current era of digital technology means that classics written more recently might require fewer years to reach their mature stage. In spite of substantial developments and advancements in this field/specialty in recent decades, there is a dearth of systematic reviews and meta-analyses among the top 100 publications. Keywords are the cornerstones of the discoverability of any manuscript and therefore, quality journals and publishers should mandate the inclusion of keywords in every publication to ensure maximum visibility of the publication across all databases.

Acknowledgments

The first author is grateful to the university for providing financial assistance under fellowship scheme for 2 years of his candidature.

Supplementary Materials

The following are available online at https://www.mdpi.com/2079-6382/9/5/219/s1, Figure S1: Distribution of citations frequency over last six decades, Table S1: List of journals which published top 100 classics, Table S2: List of keywords identified from the Elsevier Scopus database.

Author Contributions

Conceptualization, M.A.K., M.K.A., and N.A.R.; methodology, Z.M. and N.M.; software, M.I.K.; validation, Z.M. and N.M.; formal analysis, A.I.A. and P.A.; resources, J.A.A. and N.A.R.; data curation, M.I.K.; writing—original draft preparation, A.I.A. and P.A.; writing—review and editing, J.A.A., M.A.K., M.K.A., N.A.R., Z.M. and N.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  • 1.Hirsch J.E. An index to quantify an individual’s scientific research output. Proc. Natl. Acad. Sci. USA. 2005;102:16569–16572. doi: 10.1073/pnas.0507655102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ahmad P., Dummer P., Noorani T., Asif J. The top 50 most-cited articles published in the International Endodontic Journal. Int. Endod. J. 2019;52:803–818. doi: 10.1111/iej.13083. [DOI] [PubMed] [Google Scholar]
  • 3.Aslam-Pervez N., Lubek J.E. Most cited publications in oral and maxillofacial surgery: A bibliometric analysis. Oral Maxillofac. Surg. 2018;22:25–37. doi: 10.1007/s10006-017-0660-z. [DOI] [PubMed] [Google Scholar]
  • 4.Feijoo J.F., Limeres J., Fernández-Varela M., Ramos I., Diz P. The 100 most cited articles in dentistry. Clin. Oral Investig. 2014;18:699–706. doi: 10.1007/s00784-013-1017-0. [DOI] [PubMed] [Google Scholar]
  • 5.Gondivkar S.M., Sarode S.C., Gadbail A.R., Gondivkar R.S., Chole R., Sarode G.S. Bibliometric analysis of 100 most cited articles on oral submucous fibrosis. J. Oral Pathol. Med. 2018;47:781–787. doi: 10.1111/jop.12742. [DOI] [PubMed] [Google Scholar]
  • 6.Andersen J., Belmont J., Cho C.T. Journal impact factor in the era of expanding literature. J. Microbiol. Immunol. Infect. 2006;39:436–443. [PubMed] [Google Scholar]
  • 7.Heldwein F.L., Rhoden E.L., Morgentaler A. Classics of urology: A half century history of the most frequently cited articles (1955–2009) Urology. 2010;75:1261–1268. doi: 10.1016/j.urology.2009.09.043. [DOI] [PubMed] [Google Scholar]
  • 8.Fardi A., Kodonas K., Gogos C., Economides N. Top-cited articles in endodontic journals. J. Endod. 2011;37:1183–1190. doi: 10.1016/j.joen.2011.05.037. [DOI] [PubMed] [Google Scholar]
  • 9.Corbella S., Francetti L., Taschieri S., Weinstein R., Del Fabbro M. Analysis of the 100 most-cited articles in periodontology. J. Investig. Clin. Dent. 2017;8:e12222. doi: 10.1111/jicd.12222. [DOI] [PubMed] [Google Scholar]
  • 10.Kolahi J., Khazaei S. Altmetric: Top 50 dental articles in 2014. Br. Dent. J. 2016;220:569–574. doi: 10.1038/sj.bdj.2016.411. [DOI] [PubMed] [Google Scholar]
  • 11.Van Noorden R., Maher B., Nuzzo R. The top 100 papers. Nature. 2014;514:550–553. doi: 10.1038/514550a. [DOI] [PubMed] [Google Scholar]
  • 12.Tarazona B., Lucas-Dominguez R., Paredes-Gallardo V., Alonso-Arroyo A., Vidal-Infer A. The 100 most-cited articles in orthodontics: A bibliometric study. Angle Orthod. 2018;88:785–796. doi: 10.2319/012418-65.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Wu Y., Tiwana H., Durrani M., Tiwana S., Gong B., Hafeez K., Khosa F. Hallmark of success: Top 50 classics in oral and maxillofacial cone-beam computed tomography. Pol. J. Radiol. 2018;83:11–18. doi: 10.5114/pjr.2018.74343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Shuaib W., Acevedo J.N., Khan M.S., Santiago L.J., Gaeta T.J. The top 100 cited articles published in emergency medicine journals. Am. J. Emerg. Med. 2015;33:1066–1071. doi: 10.1016/j.ajem.2015.04.047. [DOI] [PubMed] [Google Scholar]
  • 15.Coats A.J. Top of the charts: Download versus citations in the International Journal of Cardiology. Int. J. Cardiol. 2005;105:123–125. doi: 10.1016/j.ijcard.2005.08.004. [DOI] [PubMed] [Google Scholar]
  • 16.Tam W.W., Wong E.L., Wong F.C., Hui D.S. Citation classics: Top 50 cited articles in ‘respiratory system’. Respirology. 2013;18:71–81. doi: 10.1111/j.1440-1843.2012.02262.x. [DOI] [PubMed] [Google Scholar]
  • 17.Baltussen A., Kindler C.H. Citation classics in anesthetic journals. Anesth. Analg. 2004;98:443–451. doi: 10.1213/01.ANE.0000096185.13474.0A. [DOI] [PubMed] [Google Scholar]
  • 18.Ponce F.A., Lozano A.M. Highly cited works in neurosurgery. Part I: The 100 top-cited papers in neurosurgical journals: A review. J. Neurosurg. 2010;112:223–232. doi: 10.3171/2009.12.JNS091599. [DOI] [PubMed] [Google Scholar]
  • 19.Arshad A.I., Ahmad P., Dummer P.M., Alam M.K., Asif J.A., Mahmood Z., Abd Rahman N., Mamat N. Citation Classics on Dental Caries: A Systematic Review. Eur. J. Dent. 2020;14:128–143. doi: 10.1055/s-0040-1703419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ahmad P., Asif J.A., Alam M.K., Slots J. A bibliometric analysis of Periodontology 2000. Periodontol. 2000. 2020;82:286–297. doi: 10.1111/prd.12328. [DOI] [PubMed] [Google Scholar]
  • 21.Ahmad P., Vincent Abbott P., Khursheed Alam M., Ahmed Asif J. A bibliometric analysis of the top 50 most cited articles published in the Dental Traumatology. Dent. Traumatol. 2020;36:89–99. doi: 10.1111/edt.12534. [DOI] [PubMed] [Google Scholar]
  • 22.Bauer A.W., Kirby W.M., Sherris J.C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 1966;45:493–496. doi: 10.1093/ajcp/45.4_ts.493. [DOI] [PubMed] [Google Scholar]
  • 23.Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415:389–395. doi: 10.1038/415389a. [DOI] [PubMed] [Google Scholar]
  • 24.Southern P.J., Berg P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1982;1:327–341. [PubMed] [Google Scholar]
  • 25.Cowan M.M. Plant products as antimicrobial agents. Clin. Microbiol. Rev. 1999;12:564–582. doi: 10.1128/CMR.12.4.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Sondi I., Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: A case study on E. coli as a model for Gram-negative bacteria. J. Colloid Interface Sci. 2004;275:177–182. doi: 10.1016/j.jcis.2004.02.012. [DOI] [PubMed] [Google Scholar]
  • 27.Brogden K.A. Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 2005;3:238–250. doi: 10.1038/nrmicro1098. [DOI] [PubMed] [Google Scholar]
  • 28.Kumar A., Roberts D., Wood K.E., Light B., Parrillo J.E., Sharma S., Suppes R., Feinstein D., Zanotti S., Taiberg L., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med. 2006;34:1589–1596. doi: 10.1097/01.CCM.0000217961.75225.E9. [DOI] [PubMed] [Google Scholar]
  • 29.Cohen S.N., Chang A.C., Hsu L. Nonchromosomal antibiotic resistance in bacteria: Genetic transformation of Escherichia coli by R-factor DNA. Proc. Natl. Acad. Sci. USA. 1972;69:2110–2114. doi: 10.1073/pnas.69.8.2110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kim J.S., Kuk E., Yu K.N., Kim J.-H., Park S.J., Lee H.J., Kim S.H., Park Y.K., Park Y.H., Hwang C.-Y., et al. Antimicrobial effects of silver nanoparticles. Nanomedicine. 2007;3:95–101. doi: 10.1016/j.nano.2006.12.001. [DOI] [PubMed] [Google Scholar]
  • 31.Stewart P.S., Costerton J.W. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358:135–138. doi: 10.1016/S0140-6736(01)05321-1. [DOI] [PubMed] [Google Scholar]
  • 32.Hancock R.E.W., Sahl H.-G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 2006;24:1551–1557. doi: 10.1038/nbt1267. [DOI] [PubMed] [Google Scholar]
  • 33.Kovach M.E., Elzer P.H., Hill D.S., Robertson G.T., Farris M.A., Roop R.M., 2nd, Peterson K.M. Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene. 1995;166:175–176. doi: 10.1016/0378-1119(95)00584-1. [DOI] [PubMed] [Google Scholar]
  • 34.Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–1773. doi: 10.1126/science.1123933. [DOI] [PubMed] [Google Scholar]
  • 35.Dorman H.J., Deans S.G. Antimicrobial agents from plants: Antibacterial activity of plant volatile oils. J. Appl. Microbiol. 2000;88:308–316. doi: 10.1046/j.1365-2672.2000.00969.x. [DOI] [PubMed] [Google Scholar]
  • 36.Sharma V.K., Yngard R.A., Lin Y. Silver nanoparticles: Green synthesis and their antimicrobial activities. Adv. Colloid Interface Sci. 2009;145:83–96. doi: 10.1016/j.cis.2008.09.002. [DOI] [PubMed] [Google Scholar]
  • 37.Mah T.F., O’Toole G.A. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 2001;9:34–39. doi: 10.1016/S0966-842X(00)01913-2. [DOI] [PubMed] [Google Scholar]
  • 38.Neu H.C. The crisis in antibiotic resistance. Science. 1992;257:1064–1073. doi: 10.1126/science.257.5073.1064. [DOI] [PubMed] [Google Scholar]
  • 39.Chopra I., Roberts M. Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 2001;65:232–260. doi: 10.1128/MMBR.65.2.232-260.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Davies J., Davies D. Origins and Evolution of Antibiotic Resistance. Microbiol. Mol. Biol. Rev. 2010;74:417–433. doi: 10.1128/MMBR.00016-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Ganz T. Defensins: Antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 2003;3:710–720. doi: 10.1038/nri1180. [DOI] [PubMed] [Google Scholar]
  • 42.Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: Isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA. 1987;84:5449–5453. doi: 10.1073/pnas.84.15.5449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Kuemmerer K. Antibiotics in the aquatic environment—A review—Part I. Chemosphere. 2009;75:417–434. doi: 10.1016/j.chemosphere.2008.11.086. [DOI] [PubMed] [Google Scholar]
  • 44.Dellit T.H., Owens R.C., McGowan J.E., Jr., Gerding D.N., Weinstein R.A., Burke J.P., Huskins W.C., Paterson D.L., Fishman N.O., Carpenter C.F., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin. Infect. Dis. 2007;44:159–177. doi: 10.1086/510393. [DOI] [PubMed] [Google Scholar]
  • 45.Wiegand I., Hilpert K., Hancock R.E.W. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 2008;3:163–175. doi: 10.1038/nprot.2007.521. [DOI] [PubMed] [Google Scholar]
  • 46.Yeaman M.R., Yount N.Y. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 2003;55:27–55. doi: 10.1124/pr.55.1.2. [DOI] [PubMed] [Google Scholar]
  • 47.Nathan C.F., Murray H.W., Wiebe M.E., Rubin B.Y. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 1983;158:670–689. doi: 10.1084/jem.158.3.670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Cushnie T.P.T., Lamb A.J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents. 2005;26:343–356. doi: 10.1016/j.ijantimicag.2005.09.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Goossens H., Ferech M., Vander Stichele R., Elseviers M., Group E.P. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet. 2005;365:579–587. doi: 10.1016/S0140-6736(05)70799-6. [DOI] [PubMed] [Google Scholar]
  • 50.Sarmah A.K., Meyer M.T., Boxall A.B.A. A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment. Chemosphere. 2006;65:725–759. doi: 10.1016/j.chemosphere.2006.03.026. [DOI] [PubMed] [Google Scholar]
  • 51.Kumarasamy K.K., Toleman M.A., Walsh T.R., Bagaria J., Butt F., Balakrishnan R., Chaudhary U., Doumith M., Giske C.G., Irfan S., et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological, and epidemiological study. Lancet Infect. Dis. 2010;10:597–602. doi: 10.1016/S1473-3099(10)70143-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Mast E.E., Margolis H.S., Fiore A.E., Brink E.W., Goldstein S.T., Wang S.A., Moyer L.A., Bell B.P., Alter M.J., Advisory Committee on Immunization P. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: Immunization of infants, children, and adolescents. MMWR Morb. Mortal. Wkly. Rep. 2005;54:1–31. [PubMed] [Google Scholar]
  • 53.Rabea E.I., Badawy M.E.T., Stevens C.V., Smagghe G., Steurbaut W. Chitosan as antimicrobial agent: Applications and mode of action. Biomacromolecules. 2003;4:1457–1465. doi: 10.1021/bm034130m. [DOI] [PubMed] [Google Scholar]
  • 54.Anthonisen N.R., Manfreda J., Warren C.P., Hershfield E.S., Harding G.K., Nelson N.A. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. 1987;106:196–204. doi: 10.7326/0003-4819-106-2-196. [DOI] [PubMed] [Google Scholar]
  • 55.Magill S.S., Edwards J.R., Bamberg W., Beldavs Z.G., Dumyati G., Kainer M.A., Lynfield R., Maloney M., McAllister-Hollod L., Nadle J., et al. Multistate Point- Prevalence Survey of Health Care- Associated Infections. N. Engl. J. Med. 2014;370:1198–1208. doi: 10.1056/NEJMoa1306801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Niederman M.S., Mandell L.A., Anzueto A., Bass J.B., Broughton W.A., Campbell G.D., Dean N., File T., Fine M.J., Gross P.A., et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am. J. Respir. Crit. Care Med. 2001;163:1730–1754. doi: 10.1164/ajrccm.163.7.at1010. [DOI] [PubMed] [Google Scholar]
  • 57.Liang S.C., Tan X.-Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., Fouser L.A. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 2006;203:2271–2279. doi: 10.1084/jem.20061308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Zankari E., Hasman H., Cosentino S., Vestergaard M., Rasmussen S., Lund O., Aarestrup F.M., Larsen M.V. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 2012;67:2640–2644. doi: 10.1093/jac/dks261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Gewirtz D.A. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 1999;57:727–741. doi: 10.1016/S0006-2952(98)00307-4. [DOI] [PubMed] [Google Scholar]
  • 60.Steers E., Foltz E.L., Graves B.S. An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics. Antibiot. Chemother. 1959;9:307–311. [PubMed] [Google Scholar]
  • 61.Hirsch R., Ternes T., Haberer K., Kratz K.L. Occurrence of antibiotics in the aquatic environment. Sci. Total Environ. 1999;225:109–118. doi: 10.1016/S0048-9697(98)00337-4. [DOI] [PubMed] [Google Scholar]
  • 62.Jenssen H., Hamill P., Hancock R.E.W. Peptide antimicrobial agents. Clin. Microbiol. Rev. 2006;19:491–511. doi: 10.1128/CMR.00056-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Laxminarayan R., Duse A., Wattal C., Zaidi A.K.M., Wertheim H.F.L., Sumpradit N., Vlieghe E., Levy Hara G., Gould I.M., Goossens H., et al. Antibiotic resistance-the need for global solutions. Lancet Infect. Dis. 2013;13:1057–1098. doi: 10.1016/S1473-3099(13)70318-9. [DOI] [PubMed] [Google Scholar]
  • 64.Park C.H., Valore E.V., Waring A.J., Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 2001;276:7806–7810. doi: 10.1074/jbc.M008922200. [DOI] [PubMed] [Google Scholar]
  • 65.Kohanski M.A., Dwyer D.J., Hayete B., Lawrence C.A., Collins J.J. A common mechanism of cellular death induced by bactericidal antibiotics. Cell. 2007;130:797–810. doi: 10.1016/j.cell.2007.06.049. [DOI] [PubMed] [Google Scholar]
  • 66.Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta. 1999;1462:55–70. doi: 10.1016/S0005-2736(99)00200-X. [DOI] [PubMed] [Google Scholar]
  • 67.Boman H.G. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 1995;13:61–92. doi: 10.1146/annurev.iy.13.040195.000425. [DOI] [PubMed] [Google Scholar]
  • 68.Hoiby N., Bjarnsholt T., Givskov M., Molin S., Ciofu O. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents. 2010;35:322–332. doi: 10.1016/j.ijantimicag.2009.12.011. [DOI] [PubMed] [Google Scholar]
  • 69.Dethlefsen L., Huse S., Sogin M.L., Relman D.A. The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing. PLoS Biol. 2008;6:2383–2400. doi: 10.1371/journal.pbio.0060280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Hughes W.T., Armstrong D., Bodey G.P., Bow E.J., Brown A.E., Calandra T., Feld R., Pizzo P.A., Rolston K.V.I., Shenep J.L., et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin. Infect. Dis. 2002;34:730–751. doi: 10.1086/339215. [DOI] [PubMed] [Google Scholar]
  • 71.Nathan C.F., Hibbs J.B., Jr. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 1991;3:65–70. doi: 10.1016/0952-7915(91)90079-G. [DOI] [PubMed] [Google Scholar]
  • 72.Li Q., Mahendra S., Lyon D.Y., Brunet L., Liga M.V., Li D., Alvarez P.J.J. Antimicrobial nanomaterials for water disinfection and microbial control: Potential applications and implications. Water Res. 2008;42:4591–4602. doi: 10.1016/j.watres.2008.08.015. [DOI] [PubMed] [Google Scholar]
  • 73.Hidron A.I., Edwards J.R., Patel J., Horan T.C., Sievert D.M., Pollock D.A., Fridkin S.K., National Healthcare Safety Network T., Participating National Healthcare S. Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect. Control Hosp. Epidemiol. 2008;29:996–1011. doi: 10.1086/591861. [DOI] [PubMed] [Google Scholar]
  • 74.Hammer K.A., Carson C.F., Riley T.V. Antimicrobial activity of essential oils and other plant extracts. J. Appl. Microbiol. 1999;86:985–990. doi: 10.1046/j.1365-2672.1999.00780.x. [DOI] [PubMed] [Google Scholar]
  • 75.Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., Gallo R.L., Leung D.Y.M. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 2002;347:1151–1160. doi: 10.1056/NEJMoa021481. [DOI] [PubMed] [Google Scholar]
  • 76.Herrero M., de Lorenzo V., Timmis K.N. Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in gram-negative bacteria. J. Bacteriol. 1990;172:6557–6567. doi: 10.1128/JB.172.11.6557-6567.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Burke J.F. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery. 1961;50:161–168. [PubMed] [Google Scholar]
  • 78.Kollef M.H., Sherman G., Ward S., Fraser V.J. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462–474. doi: 10.1378/chest.115.2.462. [DOI] [PubMed] [Google Scholar]
  • 79.Freifeld A.G., Bow E.J., Sepkowitz K.A., Boeckh M.J., Ito J.I., Mullen C.A., Raad I.I., Rolston K.V., Young J.-A.H., Wingard J.R. Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. 2011;52:E56–E93. doi: 10.1093/cid/cir073. [DOI] [PubMed] [Google Scholar]
  • 80.Ibrahim E.H., Sherman G., Ward S., Fraser V.J., Kollef M.H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118:146–155. doi: 10.1378/chest.118.1.146. [DOI] [PubMed] [Google Scholar]
  • 81.Pigeon C., Ilyin G., Courselaud B., Leroyer P., Turlin B., Brissot P., Loreal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 2001;276:7811–7819. doi: 10.1074/jbc.M008923200. [DOI] [PubMed] [Google Scholar]
  • 82.Bennett J.V., Brodie J.L., Benner E.J., Kirby W.M. Simplified, accurate method for antibiotic assay of clinical specimens. Appl. Microbiol. 1966;14:170–177. doi: 10.1128/AEM.14.2.170-177.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Chambers H.F., DeLeo F.R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 2009;7:629–641. doi: 10.1038/nrmicro2200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science. 1994;264:375–382. doi: 10.1126/science.8153624. [DOI] [PubMed] [Google Scholar]
  • 85.Cherepanov P.P., Wackernagel W. Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene. 1995;158:9–14. doi: 10.1016/0378-1119(95)00193-A. [DOI] [PubMed] [Google Scholar]
  • 86.Kong M., Chen X.G., Xing K., Park H.J. Antimicrobial properties of chitosan and mode of action: A state of the art review. Int. J. Food Microbiol. 2010;144:51–63. doi: 10.1016/j.ijfoodmicro.2010.09.012. [DOI] [PubMed] [Google Scholar]
  • 87.Hamblin M.R., Hasan T. Photodynamic therapy: A new antimicrobial approach to infectious disease? Photoch. Photobio. Sci. 2004;3:436–450. doi: 10.1039/b311900a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Carter A.P., Clemons W.M., Brodersen D.E., Morgan-Warren R.J., Wimberly B.T., Ramakrishnan V. Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature. 2000;407:340–348. doi: 10.1038/35030019. [DOI] [PubMed] [Google Scholar]
  • 89.Ganz T., Selsted M.E., Szklarek D., Harwig S.S., Daher K., Bainton D.F., Lehrer R.I. Defensins. Natural peptide antibiotics of human neutrophils. J. Clin. Investig. 1985;76:1427–1435. doi: 10.1172/JCI112120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Ceri H., Olson M.E., Stremick C., Read R.R., Morck D., Buret A. The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J. Clin. Microbiol. 1999;37:1771–1776. doi: 10.1128/JCM.37.6.1771-1776.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Classen D.C., Evans R.S., Pestotnik S.L., Horn S.D., Menlove R.L., Burke J.P. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N. Engl. J. Med. 1992;326:281–286. doi: 10.1056/NEJM199201303260501. [DOI] [PubMed] [Google Scholar]
  • 92.Ventola C.L. The antibiotic resistance crisis: Part 1: Causes and threats. Pharmacol. Ther. 2015;40:277–283. [PMC free article] [PubMed] [Google Scholar]
  • 93.Baddour L.M., Wilson W.R., Bayer A.S., Fowler V.G., Jr., Bolger A.F., Levison M.E., Ferrieri P., Gerber M.A., Tani L.Y., Gewitz M.H., et al. Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:e394–e434. doi: 10.1161/circulationaha.105.165564. [DOI] [PubMed] [Google Scholar]
  • 94.Bartlett J.G., Chang T.W., Gurwith M., Gorbach S.L., Onderdonk A.B. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N. Engl. J. Med. 1978;298:531–534. doi: 10.1056/NEJM197803092981003. [DOI] [PubMed] [Google Scholar]
  • 95.Lande R., Gregorio J., Facchinetti V., Chatterjee B., Wang Y.-H., Homey B., Cao W., Wang Y.-H., Su B., Nestle F.O., et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 2007;449:564–566. doi: 10.1038/nature06116. [DOI] [PubMed] [Google Scholar]
  • 96.Harder J., Bartels J., Christophers E., Schroder J.M. A peptide antibiotic from human skin. Nature. 1997;387:861. doi: 10.1038/43088. [DOI] [PubMed] [Google Scholar]
  • 97.Hancock R.E., Lehrer R. Cationic peptides: A new source of antibiotics. Trends Biotechnol. 1998;16:82–88. doi: 10.1016/S0167-7799(97)01156-6. [DOI] [PubMed] [Google Scholar]
  • 98.Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers. 2002;66:236–248. doi: 10.1002/bip.10260. [DOI] [PubMed] [Google Scholar]
  • 99.Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Dykes Hoberg M., Vidensky S., Chung D.S., et al. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature. 2005;433:73–77. doi: 10.1038/nature03180. [DOI] [PubMed] [Google Scholar]
  • 100.Steiner H., Hultmark D., Engstrom A., Bennich H., Boman H.G. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature. 1981;292:246–248. doi: 10.1038/292246a0. [DOI] [PubMed] [Google Scholar]
  • 101.Ruparelia J.P., Chatteriee A.K., Duttagupta S.P., Mukherji S. Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomater. 2008;4:707–716. doi: 10.1016/j.actbio.2007.11.006. [DOI] [PubMed] [Google Scholar]
  • 102.Dethlefsen L., Relman D.A. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. USA. 2011;108:4554–4561. doi: 10.1073/pnas.1000087107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Fischbach M.A., Walsh C.T. Antibiotics for Emerging Pathogens. Science. 2009;325:1089–1093. doi: 10.1126/science.1176667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Vezina C., Kudelski A., Sehgal S.N. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J. Antibiot. 1975;28:721–726. doi: 10.7164/antibiotics.28.721. [DOI] [PubMed] [Google Scholar]
  • 105.Hancock R.E., Chapple D.S. Peptide antibiotics. Antimicrob. Agents Chemother. 1999;43:1317–1323. doi: 10.1128/AAC.43.6.1317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Andersson D.I., Hughes D. Antibiotic resistance and its cost: Is it possible to reverse resistance? Nat. Rev. Microbiol. 2010;8:260–271. doi: 10.1038/nrmicro2319. [DOI] [PubMed] [Google Scholar]
  • 107.Harder J., Bartels J., Christophers E., Schroder J.M. Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 2001;276:5707–5713. doi: 10.1074/jbc.M008557200. [DOI] [PubMed] [Google Scholar]
  • 108.Epand R.M., Vogel H.J. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta. 1999;1462:11–28. doi: 10.1016/S0005-2736(99)00198-4. [DOI] [PubMed] [Google Scholar]
  • 109.Ling L.L., Schneider T., Peoples A.J., Spoering A.L., Engels I., Conlon B.P., Mueller A., Schaeberle T.F., Hughes D.E., Epstein S., et al. A new antibiotic kills pathogens without detectable resistance. Nature. 2015;517:455–459. doi: 10.1038/nature14098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Cohen M.L. Epidemiology of drug resistance: Implications for a post-antimicrobial era. Science. 1992;257:1050–1055. doi: 10.1126/science.257.5073.1050. [DOI] [PubMed] [Google Scholar]
  • 111.Umezawa H., Maeda K., Takeuchi T., Okami Y. New antibiotics, bleomycin A and B. J. Antibiot. 1966;19:200–209. [PubMed] [Google Scholar]
  • 112.Cabello F.C. Heavy use of prophylactic antibiotics in aquaculture: A growing problem for human and animal health and for the environment. Environ. Microbiol. 2006;8:1137–1144. doi: 10.1111/j.1462-2920.2006.01054.x. [DOI] [PubMed] [Google Scholar]
  • 113.Kenawy E.-R., Worley S.D., Broughton R. The chemistry and applications of antimicrobial polymers: A state-of-the-art review. Biomacromolecules. 2007;8:1359–1384. doi: 10.1021/bm061150q. [DOI] [PubMed] [Google Scholar]
  • 114.Hancock R.E. Peptide antibiotics. Lancet. 1997;349:418–422. doi: 10.1016/S0140-6736(97)80051-7. [DOI] [PubMed] [Google Scholar]
  • 115.Moazed D., Noller H.F. Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature. 1987;327:389–394. doi: 10.1038/327389a0. [DOI] [PubMed] [Google Scholar]
  • 116.Baquero F., Martinez J.-L., Canton R. Antibiotics and antibiotic resistance in water environments. Curr. Opin. Biotechnol. 2008;19:260–265. doi: 10.1016/j.copbio.2008.05.006. [DOI] [PubMed] [Google Scholar]
  • 117.Spellberg B., Guidos R., Gilbert D., Bradley J., Boucher H.W., Scheld W.M., Bartlett J.G., Edwards J., Jr., Infectious Diseases Society of America The epidemic of antibiotic-resistant infections: A call to action for the medical community from the Infectious Diseases Society of America. Clin. Infect. Dis. 2008;46:155–164. doi: 10.1086/524891. [DOI] [PubMed] [Google Scholar]
  • 118.Wang T.-T., Nestel F.P., Bourdeau V., Nagai Y., Wang Q., Liao J., Tavera-Mendoza L., Lin R., Hanrahan J.W., Mader S., et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 2004;173:2909–2912. doi: 10.4049/jimmunol.173.5.2909. [DOI] [PubMed] [Google Scholar]
  • 119.Zhang Q.-Q., Ying G.-G., Pan C.-G., Liu Y.-S., Zhao J.-L. Comprehensive Evaluation of Antibiotics Emission and Fate in the River Basins of China: Source Analysis, Multimedia Modeling, and Linkage to Bacterial Resistance. Environ. Sci. Technol. 2015;49:6772–6782. doi: 10.1021/acs.est.5b00729. [DOI] [PubMed] [Google Scholar]
  • 120.Krause A., Neitz S., Magert H.J., Schulz A., Forssmann W.G., Schulz-Knappe P., Adermann K. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000;480:147–150. doi: 10.1016/S0014-5793(00)01920-7. [DOI] [PubMed] [Google Scholar]
  • 121.Prezant T.R., Agapian J.V., Bohlman M.C., Bu X., Oztas S., Qiu W.Q., Arnos K.S., Cortopassi G.A., Jaber L., Rotter J.I. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat. Genet. 1993;4:289–294. doi: 10.1038/ng0793-289. [DOI] [PubMed] [Google Scholar]
  • 122.Fardi A., Kodonas K., Lillis T., Veis A. Top-Cited Articles in Implant Dentistry. Int. J. Oral Maxillofac. Implant. 2017;32:555–564. doi: 10.11607/jomi.5331. [DOI] [PubMed] [Google Scholar]
  • 123.Kim M.-J. A bibliometric analysis of physics publications in Korea, 1994-1998. Scientometrics. 2001;50:503–521. doi: 10.1023/A:1010514932626. [DOI] [Google Scholar]
  • 124.Jafarzadeh H., Sarraf Shirazi A., Andersson L. The most-cited articles in dental, oral, and maxillofacial traumatology during 64 years. Dent. Traumatol. 2015;31:350–360. doi: 10.1111/edt.12195. [DOI] [PubMed] [Google Scholar]
  • 125.Ugolini D., Neri M., Cesario A., Bonassi S., Milazzo D., Bennati L., Lapenna L.M., Pasqualetti P. Scientific production in cancer rehabilitation grows higher: A bibliometric analysis. Support. Care Cancer. 2012;20:1629–1638. doi: 10.1007/s00520-011-1253-2. [DOI] [PubMed] [Google Scholar]
  • 126.Von Elm E., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Ann. Intern. Med. 2007;147:573–577. doi: 10.7326/0003-4819-147-8-200710160-00010. [DOI] [PubMed] [Google Scholar]
  • 127.Kilkenny C., Browne W.J., Cuthill I.C., Emerson M., Altman D.G. Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8 doi: 10.1371/journal.pbio.1000412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Schulz K.F., Altman D.G., Moher D., CONSORT Group CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8:18. doi: 10.1186/1741-7015-8-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gøtzsche P.C., Ioannidis J.P.A., Clarke M., Devereaux P.J., Kleijnen J., Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration. BMJ. 2009;339:b2700. doi: 10.1136/bmj.b2700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130.Natarajan K., Stein D., Jain S., Elhadad N. An analysis of clinical queries in an electronic health record search utility. Int. J. Med. Inform. 2010;79:515–522. doi: 10.1016/j.ijmedinf.2010.03.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131.Asghari S., Navimipour N.J. Nature inspired meta-heuristic algorithms for solving the service composition problem in the cloud environments. Int. J. Commun. Syst. 2018;31:e3708. doi: 10.1002/dac.3708. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Antibiotics are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES